Dietary Supplement Pros and Cons: A Clinically Grounded Assessment

"Are supplements good or bad?" is the wrong question. The right questions are: which supplements, for which people, at which doses, and with what evidence? This article examines the genuine benefits and documented risks of dietary supplement use with the specificity needed for those questions to be answerable.

The Genuine Benefits of Dietary Supplements

1. Correcting Clinical Deficiencies

The strongest evidence base for supplement use is in correcting nutritional deficiencies that cannot be adequately addressed through diet alone:

Vitamin D: UK-wide deficiency is prevalent — estimates suggest 1 in 5 adults in England have low vitamin D levels. Public Health England recommends 10 micrograms/day during autumn and winter for all adults. The consequences of uncorrected deficiency — osteomalacia (soft bones), muscle weakness, increased fracture risk, potential immune impairment — are well-documented. Correction with supplementation is straightforward, low-cost, and effective.

Vitamin B12: People following strict vegan diets cannot obtain B12 from plant foods; deficiency leads to irreversible neurological damage if untreated. Supplementation at 250–1,000 micrograms/day prevents this reliably. The ~1.4 million vegans in the UK represent a population for whom B12 supplementation is not a choice but a clinical necessity.

Iron: Iron-deficiency anaemia — the most common nutritional deficiency globally — causes fatigue, reduced exercise capacity, cognitive impairment, and impaired immune function. Iron supplementation corrects deficiency effectively. GP-confirmed blood testing before starting iron supplements is essential, as excess iron is harmful.

Folate in pregnancy: Supplementation at 400 micrograms/day pre-conception and through the first trimester reduces neural tube defect risk by approximately 70%. This is among the most impactful evidence-based supplement recommendations in medicine.

2. Addressing Elevated Physiological Needs

Some life stages or conditions create needs that are difficult to meet through diet alone:

• Pregnancy: Folic acid, vitamin D, and possibly omega-3 DHA have specific evidence
• Breastfeeding: Continued vitamin D supplementation
• Older age (65+): Calcium, vitamin D, and B12 requirements increase while absorption efficiency declines
• Post-bariatric surgery: Multi-vitamin, iron, B12, calcium, vitamin D supplementation is clinically standard
• Inflammatory bowel disease: Multiple nutrient deficiencies are common; supplementation under dietitian guidance is standard care

3. Performance and Specific Clinical Applications

Creatine monohydrate: Hundreds of RCTs confirm strength (+8%), power (+14%), and lean mass benefits for resistance training. One of the most robustly evidence-supported non-pharmaceutical performance interventions available.

Glucomannan: EFSA-approved health claim for weight loss contribution (3g/day before meals in context of calorie-restricted diet). Clinical meta-analyses confirm modest but real additional weight loss vs placebo.

High-dose omega-3 (EPA) for cardiovascular risk: REDUCE-IT trial (NEJM, 2018): 4g/day EPA reduced major cardiovascular events by 25% in high-risk patients. This is a pharmaceutical preparation prescribed for specific indications.

Specific probiotic strains for antibiotic-associated diarrhoea: 2017 Cochrane Review confirms Lactobacillus rhamnosus GG and Saccharomyces boulardii significantly reduce AAD risk.

The Genuine Risks and Limitations

1. Biotin Interference with Laboratory Tests

Arguably the most clinically significant safety issue with a widely-consumed supplement. High-dose biotin (≥5mg/day — in the range of many consumer hair and nail products) causes falsely abnormal results on biotin-streptavidin immunoassay laboratory tests:

• Thyroid tests: Produces falsely low TSH and falsely elevated T4/T3 — mimicking hyperthyroidism
• Cardiac troponin: Produces falsely low troponin — masking myocardial infarction. The FDA documented deaths from delayed MI diagnosis due to biotin interference.
• Hormone tests, parathyroid hormone, vitamin levels — multiple tests affected

Many people taking biotin supplements do not disclose this to their GP. Stopping biotin at least 48 hours before any blood test is essential.

2. Drug Interactions

Several supplement ingredients have clinically significant drug interactions:

A 2016 Journal of Clinical Pharmacology review estimated that 34% of US adults take supplements alongside prescription medications, with a substantial proportion using combinations known to interact.

3. Contamination and Adulteration

The absence of pre-market testing requirements creates a quality problem:

A 2015 JAMA Internal Medicine study using DNA barcoding found that only 2 of 12 supplement companies had all products matching label claims; 60% contained species not listed on labels.

Adulteration in weight loss and sports supplements is documented and recurring:

• The FDA and MHRA regularly issue alerts for weight loss supplements containing sibutramine (withdrawn from market due to cardiovascular risks), phenolphthalein (carcinogen), and undisclosed stimulants
• Sports supplements containing WADA-prohibited substances create doping violations for athletes even without deliberate intent

Third-party testing (Informed Sport, NSF, IFOS) provides quality assurance in the absence of mandatory pre-market testing.

4. Risk in Specific Populations

Pregnancy:

• Vitamin A (retinol) above 3,000 micrograms/day is teratogenic — causing malformations. Supplements marketed for "skin health" or "anti-ageing" may contain high retinol; pregnant women should avoid these. (Beta-carotene, the plant-form pro-vitamin A, does not carry this risk.)
• High-dose caffeine supplements carry pregnancy risk — NHS recommends maximum 200mg/day
• Herbal supplements in pregnancy carry variable and largely unknown risk profiles — most are not studied in pregnant populations

Kidney disease:

• Creatine: raises serum creatinine (can confound kidney function assessment); discuss with GP
• High-dose vitamin C: oxalate formation risk with prolonged high doses in people prone to kidney stones
• High-dose potassium: accumulates in renal failure

Anticoagulated patients (warfarin, direct oral anticoagulants):

• Multiple supplement ingredients affect coagulation; any new supplement requires GP discussion

5. The Financial Cost vs. Evidence Reality

The supplement industry extracts significant expenditure for products where evidence is absent or weak. A realistic assessment of popular categories:

6. Substitution Effect

Perhaps the most insidious risk of supplements marketed for health conditions: the belief that supplementation adequately addresses a condition that requires proper medical assessment and treatment.

Someone experiencing fatigue who purchases iron supplements without testing may have iron deficiency — but may equally have hypothyroidism, vitamin D deficiency, sleep disorder, depression, or chronic illness. Taking iron without testing delays appropriate diagnosis.

Someone taking "immune support" supplements instead of investigating recurrent infections delays assessment of potential immune deficiency.

The substitution of supplement-taking for appropriate medical assessment is not a safety risk of the supplement itself, but a systemic risk of unstructured self-prescribing.

Principles for Balanced Supplement Use

1. Test before supplementing where blood tests can identify deficiency — vitamin D, iron, B12, folate (in pregnancy planning). Supplement specifically what is deficient.

2. Prioritise supplements with Grade A evidence for specific indications over broad-category "wellness" products with marketing-based claims.

3. Always inform your GP and pharmacist about supplements you take, particularly before blood tests (biotin) and if you are on prescription medications (drug interactions).

4. Choose third-party tested products — Informed Sport, NSF, IFOS — which verify that what is on the label is in the product.

5. Set a budget ceiling for supplements without confirmed deficiency or Grade A evidence — the opportunity cost of spending £50/month on ineffective supplements is £600/year not spent on food quality, gym membership, or other evidence-based health investments.

Conclusion

Dietary supplements have genuine benefits — correcting deficiencies that cause real harm (vitamin D, B12, iron, folate), supporting specific populations with elevated needs, and providing evidence-based performance support (creatine, protein). They also carry genuine documented risks — drug interactions (St. John's Wort, berberine, high-dose vitamin E, fish oil), laboratory test interference (biotin), contamination and adulteration (particularly in weight loss and sports categories), and specific risks in pregnancy, kidney disease, and anticoagulated patients. The net value of supplementation depends entirely on which supplement, for which person, at which dose, and with which evidence base. Applying the same evidence standard to supplements as to other health interventions — systematic review evidence, EFSA-approved claims, confirmed deficiency — produces better decisions than either wholesale acceptance or wholesale rejection of the supplement category.

Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice. Supplement interactions with medications should be discussed with a GP or pharmacist. Do not discontinue prescribed medications or use supplements to self-treat diagnosed conditions without medical advice.